In conclusion, Gpr35 not only delays PD progression by modulating gut microbiota and metabolites but also directly regulates PD pathogenesis in the nervous system by controlling inflammation, oxidative stress, and neuronal apoptosis. Here, GPR35 is linked to Parkinson disease.